MPT
Medical Properties Trust, Inc.
3.50$
-1.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +29.0% | +49.7% | +14.4% | +40.5% | +60.4% | +16.3% | +21.9% | -4.2% | -6.9% | -21.9% | +4.9% | |
| – | +62.9% | +32.6% | -20.6% | +69.1% | +935.1% | -10.6% | +12.7% | -62.1% | -18.9% | -6.0% | +38.2% | |
| – | +214.4% | +35.3% | -57.4% | +106.0% | +752.8% | -62.4% | -16.5% | -48.7% | +6.1% | +32.9% | +62.7% | |
| – | +214.4% | +35.3% | -57.4% | +106.0% | +752.8% | -62.4% | -16.5% | -48.7% | +6.1% | +32.9% | +62.7% | |
| – | +103.4% | -76.1% | +35.2% | +51.6% | +816.9% | +5.0% | +11.4% | -58.4% | -17.6% | -13.1% | +28.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -9.2% | -17.4% | +0.2% | |
| – | +20.3% | +136.0% | +15.3% | +49.6% | +25.6% | +114.4% | +7.1% | – | – | – | – | |
| – | +51.6% | +48.1% | -9.6% | +63.8% | +43.5% | +27.5% | +27.3% | -8.4% | -3.5% | -11.3% | +9.9% | |
| – | +18.4% | +19.2% | +36.5% | +0.8% | +27.1% | +50.5% | +38.5% | +159.7% | +24.4% | -57.0% | +42.7% | |
| – | +223,858.5% | -78.9% | -99.7% | – | – | +816.1% | -91.8% | +22,033.0% | +62.9% | -76.1% | +76.4% | |
| – | – | +26.1% | +29.8% | +21.0% | +35.4% | +35.5% | +55.8% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -3.6% | -8.4% | -0.7% | +14.3% | |
| – | +2.8% | +52.1% | +54.5% | +17.6% | +83.9% | +4.4% | +15.0% | +1.8% | -11.2% | -36.7% | -4.7% | |
| – | – | – | – | – | – | – | – | – | -935.7% | – | – | |
| – | +11.8% | +28.0% | +19.6% | +34.2% | +22.2% | +23.9% | +11.3% | +1.5% | -0.1% | +0.3% | +0.1% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.